Update and perspectives on congenital disorders of glycosylation

Glycobiology

Volumn 11, Issue 12, 2001, Pages

  Freeze, Hudson H ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Congenital disorders of glycosylation; Genetic disorder; LAD II; Mannose; N linked oligosaccharide

Indexed keywords

ALPHA GLUCOSIDASE; GLYCOSYLTRANSFERASE; GUANOSINE DIPHOSPHATE FUCOSE; MANNOSE PHOSPHATE; MANNOSE PHOSPHATE ISOMERASE; N ACETYLGLUCOSAMINYLTRANSFERASE; PHOSPHOMANNOMUTASE; TRANSFERRIN;

AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL FEATURE; CONGENITAL DISORDER OF GLYCOSYLATION; CONTROLLED STUDY; ENZYME DEFICIENCY; GENETIC DISORDER; HEALTH PRACTITIONER; HUMAN; INBORN ERROR OF METABOLISM; ION EXCHANGE CHROMATOGRAPHY; ISOELECTRIC FOCUSING; MEDICAL EDUCATION; MEDICAL PRACTICE; MOLECULAR GENETICS; MOUSE; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALIA;

EID: 0035716899     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/11.12.129R     Document Type: Review

References (197)

1. Congenital disorders of glycosylation: Genetic model systems lead the way
2. Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene
3. Cloning and expression of a proteoglycan UDP-galactose:beta-xylose beta1, 4-galactosyltransferase I. A seventh member of the human beta4-galactosyltransferase gene family
4. Saving lives with sugar
5. Searching for medicine's sweet spot
6. Direct utilization of mannose for mammalian glycoprotein biosynthesis
7. Oral ingestion of mannose elevates blood mannose levels: A first step toward a potential therapy for carbohydrate-deficient glycoprotein syndrome type I
8. Requirement of the lec35 gene for all known classes of monosaccharide-p-dolichol-dependent glycosyl-transferase reactions in mammals
9. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: A critical review of preanalysis, analysis, and interpretation
10. The impact of glycobiology on medicine
11. Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome
12. The Saccharomyces cerevisiae DPM1 gene encoding dolichol-phosphate-mannose synthase is able to complement a glycosylation-defective mammalian cell line
13. Leukocyte adhesion deficiency type II
14. Aspects of gene regulation during the UPR in human cells
15. Mannans and glucomannans
16. Notch signaling: Fringe really is a glycosyltransferase
17. sqv-3, -7, and -8, a set of genes affecting morphogenesis in Caenorhabditis elegans, encode enzymes required for glycosaminoglycan biosynthesis
18. The dolichol pathway of N-linked glycosylation
19. A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide
20. Ordered assembly of the asymmetrically branched lipid-linked oligosaccharide in the endoplasmic reticulum is ensured by the substrate specificity of the individual glycosyltransferases
21. Defective galactosylation of serum transferrin in galactosemia
22. Prenatal diagnosis of the carbohydrate-deficient glycoprotein syndrome type 1A (CDG1A) by a combination of enzymology and genetic linkage analysis after amniocentesis or chorionic villus sampling
23. Carbohydrate-deficient glycoprotein syndrome: Normal glycosylation in the fetus
24. The physiological significance of metabolite channeling: An idea whose time has come
25. Glucose metabolism and the channeling of glycolytic intermediates in permeabilized L-929 cells
26. Determination of glycan structures and molecular masses of the glycovariants of serum transferrin from a patient with carbohydrate deficient syndrome type II
27. Effect of ethanol administration on the level of dolichol in rat liver microsomes and Golgi apparatus
28. Studies of mannose metabolism and effects of long-term mannose ingestion in the mouse
29. Physiological effects of mannans, galactomannans, and glucomannans
30. Phosphomannose isomerase deficiency with cyclic vomiting and congenital hepatic fibrosis
31. A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency
32. Congenital hepatic fibrosis in 3 siblings with phosphomannose isomerase deficiency
33. Hyperinsulinemic hypoglycemia as presenting symptom in phosphomannose isomerase deficiency: A new presentation of carbohydrate-deficient glycoprotein syndrome treatable by mannose
34. Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose
35. A broad spectrum of clinical presentations in congenital disorders of glycosylation I: A series of 26 cases
36. A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency
37. Phenotypes of patients with "simple" Mendelian disorders are complex traits: Thresholds, modifiers, and systems dynamics
38. Regulation of the dolichol pathway in human fibroblasts by the endoplasmic reticulum unfolded protein response
39. Protein C-mannosylation is enzyme-catalysed and uses dolichyl-phosphate-mannose as a precursor
40. The link between heparan sulfate and hereditary bone disease: Finding a function for the EXT family of putative tumor suppressor proteins
41. Congenital disorder of glycosylation Ia with deficient phosphomannomutase activity but normal plasma glycoprotein pattern
42. Alteration of mannose transport in fibroblasts from type I carbohydrate deficient glycoprotein syndrome patients
43. Genetic and epidemiological aspects of the carbohydrate-deficient glycoprotein syndrome
44. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy
45. The molecular biology of galactosemia
46. O-mannosyl glycans in mammals
47. Leukocyte adhesion deficiency II-from A to almost Z
48. Brief report: Recurrent severe infections caused by a novel leukocyte adhesion deficiency
49. Leukocyte adhesion deficiency (LAD) II
50. Lectin analyses of glycoprotein hormones in patients with congenital disorders of glycosylation
51. Carbohydrate-deficient glycoprotein syndrome: Beyond the screen
52. Disorders in protein glycosylation and potential therapy: Tip of an iceberg?
53. Opinion: The pathology of N-glycosylation - Stay the middle, avoid the risks
54. Molecular basis of carbohydrate-deficient glycoprotein syndromes type I with normal phosphomannomutase activity
55. Balancing N-linked glycosylation to avoid disease
56. Rambam-Hasharon syndrome of psychomotor retardation, short stature, defective neutrophil motility, and Bombay phenotype
57. Studies on phosphomannose isomerase. I. Isolation, homogeneity measurements, and determination of some physical properties
58. Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse
59. β-Trace protein in human cerebrospinal fluid: A diagnostic marker for N-glycosylation defects in brain
60. Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis
61. High residual activity of PMM2 in patients' fibroblasts: Possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency)
62. Congenital disorder of glycosylation-Ic: Case report and genetic defect
63. Multiple serum protein abnormalities in carbohydrate-deficient glycoprotein syndrome: Pathognomonic finding of two-dimensional electrophoresis?
64. The remodeling of glycoconjugates in mice
65. Microheterogeneity of serum glycoproteins in patients with chronic alcohol abuse compared with carbohydrate-deficient glycoprotein syndrome type I
66. Glycoprotein biosynthesis in yeast
67. Yeast mutants deficient in protein glycosylation
68. A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic
69. Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic
70. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie
71. Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1
72. Defects of N-Glycan Synthesis
73. Phosphomannose isomerase deficiency: A carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation
74. Inhibition of phosphomannose isomerase by fructose 1-phosphate: An explanation for defective N-glycosylation in hereditary fructose intolerance
75. Carbohydrate-deficient glycoprotein syndrome type II: An autosomal recessive disease due to mutations in the N-acetylglucosaminyltransferase II gene
76. Carbohydrate deficient glycoprotein syndrome type II: A deficiency in Golgi localised N-acetyl-glucosaminyltransferase II
77. Familial psychomotor retardation with markedly fluctuating serum prolactin, FSH and GH levels, partial TBG deficiency, increased serum arysulphatase A and increased CSF protein: A new syndrome?
78. Leukocyte adhesion deficiency type II is a generalized defect of de novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium
79. Carbohydrate-deficient glycoprotein syndromes: Inborn errors of protein glycosylation
80. Dolichol phosphate mannose synthase (DPMI) mutations define congenital disorder of glycosylation Ie (CDG-Ie)
81. Failure of short-term mannose therapy of patients with carbohydrate-deficient glycoprotein syndrome type 1A
82. Congenital disorder of glycosylation type Ia (CDG-Ia): Phenotypic spectrum of the R141H/F119L genotype
83. Carbohydrate-deficient glycoprotein syndrome type 1A: Expression and characterisation of wild type and mutant PMM2 in E. coli
84. Conformational disease
85. 2-PP-dolichyl glucosyltransferase
86. Abnormal synthesis of mannose 1-phosphate derived carbohydrates in carbohydrate-deficient glycoprotein syndrome type I fibroblasts with phosphomannomutase deficiency
87. 2-PP-dolichyl mannosyltransferase
88. Diseases of aberrant glycosylation
89. A mutation in the human Lec35/MPUDU1 gene cause Congenital Disorder of Glycosylation Type If (CDG-If)
90. Carbohydrate-deficient glycoprotein syndrome
91. Abnormal synthesis of dolichol-linked oligosaccharides in carbohydrate-deficient glycoprotein syndrome
92. Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry
93. Carbohydrate composition of serum transferrin isoforms from patients with high alcohol consumption
94. Diversity of congenital disorders of glycosylation
95. Semi-automatic method for determination of different isoforms of carbohydrate-deficient transferrin
96. Glycosylation, immunity, and autoimmunity
97. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency
98. A new type of carbohydrate-deficient glycoprotein syndrome due to a decreased import of GDP-fucose into the Golgi
99. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter
100. Human dolichol-phosphate-mannose synthase consists of three subunits, DPM1, DPM2 and DPM3
101. DPM2 regulates biosynthesis of dolichol phosphate-mannose in mammalian cells: Correct subcellular localization and stabilization of DPM1, and binding of dolichol phosphate
102. Congenital disorders of glycosylation: Glycosylation defects in man and biological models for their study
103. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism
104. Correction of leukocyte adhesion deficiency type II with oral fucose
105. Mannose therapy in carbohydrate-deficient glycoprotein syndrome type I--first results of the German multicenter study
106. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia)
107. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome)
108. PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is localized on chromosome 22q13
109. Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A
110. Mannose supplementation in carbohydrate-deficient glycoprotein syndrome type I and phosphomannomutase deficiency
111. Continuous mannose infusion in carbohydrate-deficient glycoprotein syndrome type I
112. Herpes simplex virus: Discovering the link between heparan sulphate and hereditary bone tumours
113. Demonstration that Golgi endo-alpha-D-mannosidase provides a glucosidase-independent pathway for the formation of complex N-linked oligosaccharides of glycoproteins
114. Characterization of the endomannosidase pathway for the processing of N-linked oligosaccharides in glucosidase II-deficient and parent mouse lymphoma cells
115. Modifier genes in mice and humans
116. Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy
117. Galactose metabolism by the mouse with galactose-1-phosphate uridyltransferase deficiency
118. Molecular basis of disorders of human galactose metabolism: Past, present, and future
119. The emergence of a basolateral 1-deoxymannojirimycin-sensitive mannose carrier is a function of intestinal epithelial cell differentiation. Evidence for a new inhibitory effect of 1-deoxymannojirimycin on transport
120. Dual effect of 1-deoxymannojirimycin on the mannose uptake and on the N-glycan processing of the human colon cancer cell line HT-29
121. Molecular basis for the progeroid variant of Ehlers-Danlos syndrome. Identification and characterization of two mutations in galactosyltransferase I gene
122. Tissue- and site-specific DNA recombination in transgenic mice
123. Cloning and sequencing of the yeast gene for dolichol phosphate mannose synthase, an essential protein
124. Abnormal galactosylation of complex carbohydrates in cultured fibroblasts from patients with galactose-1-phosphate uridyltransferase deficiency
125. Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts
126. Mannose enters mammalian cells using a specific transporter that is insensitive to glucose
127. Human fibroblasts prefer mannose over glucose as a source of mannose for N-glycosylation. Evidence for the functional importance of transported mannose
128. Purification to apparent homogeneity and properties of pig kidney L-fuctose kinase
129. Letter to the Glyco-Forum. Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: An updated nomenclature for CDG
130. Congenital hepatic fibrosis combined with protein-losing enteropathy and recurrent thrombosis
131. Kinetic properties and tissular distribution of mammalian phosphomannomutase isozymes
132. Effect of mutations found in carbohydrate-deficient glycoprotein syndrome type IA on the activity of phosphomannomutase 2
133. Hypoglycosylation of a brain glycoprotein (β-trace protein) in CDG syndromes due to phosphomannomutase deficiency and N-acetylglucosaminyl-transferase II deficiency
134. Carbohydrate-deficient glycoprotein syndrome: Not an N-linked oligosaccharide processing defect, but an abnormality in lipid-linked oligosaccharide biosynthesis?
135. Purification, cDNA cloning and heterologous expression of human phosphomannose isomerase
136. Purification and characterization of fungal and mammalian phosphomannose isomerases
137. A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: Galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome
138. Genetic dissection of complex traits: An overview
139. Galactomannans
140. Isolation of the ALG6 locus of Saccharomyces cerevisiae required for glucosylation in the N-linked glycosylation pathway
141. Mannose supplementation corrects GDP-mannose deficiency in cultured fibroblasts from some patients with congenital disorders of glycosylation (CDG)
142. Terminal glycosylation in cystic fibrosis
143. Terminal glycosylation and disease: Influence on cancer and cystic fibrosis
144. Diseases with deficiencies in asparagine-linked glycosylation. A. Carbohydrate-deficient glycoprotein syndromes
145. Glycoconjugate diseases
146. Carbohydrate-deficient glycoprotein syndrome type II
147. MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If
148. Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib)
149. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia)
150. Comparative analysis of the phosphomannomutase genes PMM1, PMM2 and PMM2psi: The sequence variation in the processed pseudogene is a reflection of the mutations found in the functional gene
151. Membrane-permeant derivatives of cyclic AMP optimized for high potency, prolonged activity, or rapid reversibility
152. Acetoxymethyl esters of phosphates, enhancement of the permeability and potency of cAMP
153. QLS motif in transmembrane helix VII of the glucose transporter family interacts with the C-1 position of D-glucose and is involved in substrate selection at the exofacial binding site
154. Defective galactosylation in galactosemia: Is low cell UDP-galactose an explanation?
155. Galactosemia unsolved
156. Proteoglycans and pattern formation: Sugar biochemistry meets developmental genetics
157. Genetic dissection of proteoglycan function in Drosophila and C. elegans
158. Possible reasons why heavy drinking increases carbohydrate-deficient transferrin
159. Gene inactivation in Lec35.1 (mannosylation-defective) Chinese hamster ovary cells. A cautionary note
160. PMI40, an intron-containing gene required for early steps in yeast mannosylation
161. Glycosylation mutants of animal cells
162. Diagnosis of the carbohydrate-deficient glycoprotein syndrome by analysis of transferrin in filter paper blood spots
163. Carbohydrate-deficient transferrin in serum in patients with liver diseases
164. Carbohydrate deficient serum transferrin in a new systemic hereditary syndrome
165. Failure to diagnose carbohydrate-deficient glycoprotein syndrome prenatally
166. Transferrin phenotype and level of carbohydrate-deficient transferrin in healthy individuals
167. Carbohydrate-deficient transferrin (CDT) in serum in women with early alcohol addiction
168. A neurodystrophic syndrome resembling carbohydrate-deficient glycoprotein syndrome type III
169. Isoforms and levels of transferrin, antithrombin, alpha(1)-antitrypsin and thyroxine-binding globulin in 48 patients with carbohydrate-deficient glycoprotein syndrome type I
170. Carbohydrate-deficient glycoprotein syndrome - A fourth subtype
171. Carbohydrate-deficient transferrin in galactosaemia
172. Carbohydrate-deficient glycoprotein (CDG) syndrome - A new variant, type III
173. Impairment of the Golgi GDP-L-fucose transport and unresponsiveness to fucose replacement therapy in LAD II patients
174. Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development
175. Transport of UDP-galactose into the Golgi lumen regulates the biosynthesis of proteoglycans
176. A homologue of Saccharomyces cerevisiae Dpm1p is not sufficient for synthesis of dolichol-phosphate-mannose in mammalian cells
177. A unique pattern of coagulation abnormalities in carbohydrate-deficient glycoprotein syndrome
178. Carbohydrate-deficient glycoprotein syndrome type 1a: A variant phenotype with borderline cognitive dysfunction, cerebellar hypoplasia, and coagulation disturbances
179. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I
180. Synergistic heterozygosity: Disease resulting from multiple partial defects in one or more metabolic pathways
181. Identification of four novel PMM2 mutations in congenital disorders of glycosylation (CDG) Ia French patients
182. Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome
183. Physiologic and disease-inducing activities of asparagine-linked glycans in a model of congenital disorder of glycosylation (CDG) type IIa
184. Expression cloning of a novel suppressor of the Lec15 and Lec35 glycosylation mutations of Chinese hamster ovary cells
185. Expression cloning of a novel suppressor of the Lec15 and Lec35 glycosylation mutations of Chinese hamster ovary cells [Additions and Corrections]
186. Functional analysis of novel mutations in a congenital disorder of glycosylation ia patient with mixed asian ancestry
187. Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type ib: Long-term outcome and effects of mannose supplementation
188. Functional significance of PMM2 mutations in mildly affected patients with congenital disorders of glycosylation Ia
189. Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation
190. Analysis of multiple mutations in the hALG6 gene in a patient with congenital disorder of glycosylation Ic
191. Congenital disorders of glycosylation: Have you encountered them?
192. L-fucose is accumulated via a specific transport system in eukaryotic cells
193. The carbohydrate-deficient glycoprotein syndrome: An experiment of nature in glycosylation
194. Molecular basis of multiple exostoses: Mutations in the EXT1 and EXT2 genes
195. Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. Evidence of asparagine-N-linked oligosaccharide transfer deficiency
196. Electrospray ionization-mass spectrometric analysis of serum transferrin isoforms in patients with carbohydrate-deficient glycoprotein syndrome
197. Golgi apparatus immunolocalization of endomannosidase suggests post-endoplasmic reticulum glucose trimming: Implications for quality control